ProShare Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-161
| Closed | -$56K | – | 1811 |
|
2019
Q3 | $56K | Sell |
161
-4
| -2% | -$1.39K | ﹤0.01% | 1594 |
|
2019
Q2 | $152K | Sell |
165
-19
| -10% | -$17.5K | ﹤0.01% | 1488 |
|
2019
Q1 | $294K | Buy |
184
+2
| +1% | +$3.2K | ﹤0.01% | 1270 |
|
2018
Q4 | $340K | Sell |
182
-32
| -15% | -$59.8K | ﹤0.01% | 1090 |
|
2018
Q3 | $505K | Sell |
214
-11
| -5% | -$26K | ﹤0.01% | 1094 |
|
2018
Q2 | $776K | Sell |
225
-13
| -5% | -$44.8K | 0.01% | 930 |
|
2018
Q1 | $677K | Sell |
238
-37
| -13% | -$105K | ﹤0.01% | 980 |
|
2017
Q4 | $709K | Buy |
275
+24
| +10% | +$61.9K | ﹤0.01% | 978 |
|
2017
Q3 | $713K | Buy |
251
+14
| +6% | +$39.8K | 0.01% | 828 |
|
2017
Q2 | $561K | Sell |
237
-20
| -8% | -$47.3K | 0.01% | 917 |
|
2017
Q1 | $647K | Sell |
257
-63
| -20% | -$159K | 0.01% | 912 |
|
2016
Q4 | $722K | Buy |
320
+35
| +12% | +$79K | 0.01% | 921 |
|
2016
Q3 | $715K | Sell |
285
-53
| -16% | -$133K | 0.01% | 800 |
|
2016
Q2 | $1.04M | Buy |
338
+3
| +0.9% | +$9.19K | 0.01% | 707 |
|
2016
Q1 | $1.06M | Sell |
335
-15
| -4% | -$47.6K | 0.01% | 680 |
|
2015
Q4 | $1.8M | Buy |
350
+37
| +12% | +$190K | 0.02% | 542 |
|
2015
Q3 | $996K | Sell |
313
-23
| -7% | -$73.2K | 0.01% | 670 |
|
2015
Q2 | $1.35M | Sell |
336
-26
| -7% | -$104K | 0.02% | 646 |
|
2015
Q1 | $1.45M | Buy |
362
+47
| +15% | +$188K | 0.02% | 666 |
|
2014
Q4 | $1.55M | Sell |
315
-11
| -3% | -$54K | 0.02% | 650 |
|
2014
Q3 | $1.33M | Sell |
326
-81
| -20% | -$329K | 0.02% | 953 |
|
2014
Q2 | $1.65M | Sell |
407
-218
| -35% | -$882K | 0.02% | 899 |
|
2014
Q1 | $2.84M | Buy |
625
+435
| +229% | +$1.98M | 0.04% | 540 |
|
2013
Q4 | $667K | Sell |
190
-159
| -46% | -$558K | 0.01% | 1037 |
|
2013
Q3 | $1.44M | Buy |
349
+46
| +15% | +$189K | 0.03% | 606 |
|
2013
Q2 | $1.2M | Buy |
+303
| New | +$1.2M | 0.02% | 734 |
|